Sales 2024 * | 48.78B 45.63B 66.68B | Sales 2025 * | 50.62B 47.34B 69.19B | Capitalization | 200B 187B 273B |
---|---|---|---|---|---|
Net income 2024 * | 10.37B 9.7B 14.18B | Net income 2025 * | 11.9B 11.12B 16.26B | EV / Sales 2024 * | 4.35 x |
Net Debt 2024 * | 12.65B 11.83B 17.29B | Net Debt 2025 * | 11.18B 10.46B 15.29B | EV / Sales 2025 * | 4.17 x |
P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
16.7
x | Employees | 76,057 |
Yield 2024 * |
3.69% | Yield 2025 * |
3.82% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
-9.61% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |